Professor, Medicine, University of Oklahoma College of Medicine
Hematology
Dr. Philip C. Comp, MD
|
|
Give Review
Philip C. Comp, MD practices Hematology. He graduated from University of Washington School of Medicine. He received 2 awards: "Elected Member" and "Whos Who in Medicine and Healthcare". Philip Comp is a published doctor. He published 82 publications, including: 'Advances in the etiology and treatment of venous thromboembolism.' Philip Comp accepts Medicare.
Publications
- Phosphofructokinase deficiency and portal and mesenteric vein thrombosis.
- The relationship between arterial elasticity and metabolic syndrome features.
- Should coagulation tests be used to determine which oral contraceptive users have an increased risk of thrombophlebitis?
- Selective factor Xa inhibition improves efficacy of venous thromboembolism prophylaxis in orthopedic surgery.
- B lymphopoiesis is active throughout human life, but there are developmental age-related changes.
- Treatment and management of acute venous thromboembolic Disease.
- Effect of cilostazol in patients with intermittent claudication: a randomized, double-blind, placebo-controlled study.
- Coagulolysis assay in the detection of deep vein thrombosis in the orthopedic patient. A preliminary report.
- A lysine-absorbable plasminogen activator is elevated in conditions associated with increased fibrinolytic activity.
- Protein C, isolation and potential use in prevention of thrombosis.
- Coagulation and thrombosis with OC use: physiology and clinical relevance.
- Phospholipid composition controls thromboplastin sensitivity to individual clotting factors.
- Laboratory evaluation of protein S status.
- Activation of protein C in vivo.
- The activation and effects of protein C, an antithrombotic protein, in vivo.
- Generation of fibrinolytic activity by infusion of activated protein C into dogs.
- Familial protein S deficiency is associated with recurrent thrombosis.
- Heparin-protein C interaction.
- The dilute whole blood clot lysis assay: a screening method for identifying postoperative patients with a high incidence of deep venous thrombosis.
- A 5.3-kb deletion including exon XIII of the protein S alpha gene occurs in two protein S-deficient families.
- Oral contraceptives and gender affect protein S status.
- Functional and immunologic protein S levels are decreased during pregnancy.
- An abnormal plasma distribution of protein S occurs in functional protein S deficiency.
- Relationship between protein C antigen and anticoagulant activity during oral anticoagulation and in selected Disease states.
- Analysis of protein C and protein S in Disease states.
- Traces of factor VIIa modulate thromboplastin sensitivity to factors V, VII, X, and prothrombin.
- Bimodal distribution of soluble endothelial protein C receptor levels in healthy populations.
- A rapid purification of streptokinase by affinity chromatography.
- In vitro studies with the platelet-reactive antibody 50H.19 and its fragments.
- An association between plasma free protein s concentration and risk of coronary heart Disease in middle-aged men.
- Fibrinogen levels in women having coronary angiography.
- Weekly treatment of diet/drug-resistant hypercholesterolemia with the heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) system by selective p...
- Animal studies of protein C physiology.
- Biochemical and physiological aspects of protein c.
- Coumarin-induced skin necrosis. Incidence, mechanisms, management and avoidance.
- Hereditary disorders predisposing to thrombosis.
- Recent advances in understanding clotting and evaluating patients with recurrent thrombosis.
- On the role of phosphatidylethanolamine in the inhibition of activated protein C activity by antiphospholipid antibodies.
- Selective removal of plasma low density lipoprotein with the HELP system: biweekly versus weekly therapy.
- Activated factor VII levels in patients with angiographically confirmed coronary artery Disease.
- Cytokine-induced alteration of platelet and hemostatic function.
- Blockade of protein C activation reduces microvascular surgical blood loss.
- Afibrinogenemia and hypobetalipoproteinemia in a kindred.
- Recurrent venous thromboembolism in patients with a partial deficiency of protein S.
- Deficiency of plasma protein S, protein C, or antithrombin III and arterial thrombosis.
- Activated protein C inhibits platelet prothrombin-converting activity.
- Advances in the etiology and treatment of venous thromboembolism.
- Anticoagulation proteins C and S.
- The regulation of hemostasis: the protein C system.
- Thrombophilic mechanisms of OCs.
- Hyperhomocysteinemia, aortic thrombus, and peripheral arterial emboli--a case report.
- Antibodies to thrombomodulin are found in patients with lupus anticoagulant and unexplained thrombosis.
- Free protein S levels are elevated in familial C4b-binding protein deficiency.
- Clinical implications of the protein C/protein S system.
- Preventing systemic embolism in patients with abnormal ventricular function.
- Safety and anticoagulation effect of a low-dose combination of warfarin and aspirin in clinically stable coronary artery Disease. Coumadin Aspirin Reinfarction (CARS) ...
- Age and stage dependency of estrogen receptor expression by lymphocyte precursors.
- Acquired deficiencies of protein S. Protein S activity during oral anticoagulation, in liver Disease, and in disseminated intravascular coagulation.
- Contraceptive choices in women with coagulation disorders.
- Determination of functional levels of protein C, an antithrombotic protein, using thrombin-thrombomodulin complex.
- Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation.
- Decrease in endothelial cell-dependent protein C activation induced by thrombomodulin by treatment with cyclosporine.
- Monitoring low-dose warfarin therapy by a central laboratory and implications for clinical trials and patient care. The Coumadin Aspirin Reinfarction (CARS) Pilot Stud...
- The clinical validity of normal compression ultrasonography in outpatients suspected of having deep venous thrombosis.
- Dose-response study of recombinant human soluble thrombomodulin (ART-123) in the prevention of venous thromboembolism after total hip replacement.
- A comparison of danaparoid and warfarin for prophylaxis against deep vein thrombosis after total hip replacement: The Danaparoid Hip Arthroplasty Investigators Group.
- Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal sur...
- Predictive value of compression ultrasonography for deep vein thrombosis in symptomatic outpatients: clinical implications of the site of vein noncompressibility.
- Effect of treatment with low-dose warfarin-aspirin on activated factor VII.
- Relatively normal human lymphopoiesis but rapid turnover of newly formed B cells in transplanted nonobese diabetic/SCID mice.
- Dose-response study of recombinant factor VIIa/tissue factor inhibitor recombinant nematode anticoagulant protein c2 in prevention of postoperative venous thromboembol...
- Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. Enoxaparin Clinical Trial Group.
- Laboratory issues in diagnosing abnormalities of protein C, thrombomodulin, and endothelial cell protein C receptor.
- Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement.
- Early lymphoid progenitors in mouse and man are highly sensitive to glucocorticoids.
- Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569].
- New perspectives on vitamin E: gamma-tocopherol and carboxyelthylhydroxychroman metabolites in biology and medicine.
- Outcomes of dalteparin use following total knee arthroplasty: a retrospective analysis.
- Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery.
- The influence of obesity on calf blood flow and vascular reactivity in older adults.
- Abnormal melt curve profile during prothrombin 20210G --> A analysis due to the 20209C --> T variant.
Schools
University of Washington
Hospital Of The University Of Pennsylvania
University of Oklahoma Health Sciences Center
Conditions Treated
- Asthma
- Bronchitis
- COPD (Chronic Obstructive Pulmonary Disease)
- Dermatitis Due to Drugs
- View All
Doctors Specialties
- Internal Medicine
- Hematology
Accepted Insurances
Awards
- Elected Member
- Whos Who in Medicine and Healthcare
Education
-
University Hospital & Clinics -
University of Pennsylvania Health System -
University of Washington School of Medicine
Drug Facts
| NPI NUMBER | 1790754729 | |
| NPPES Provider LastName | COMP | |
| NPPES Provider FirstName | PHILIP | |
| NPPES Provider ZIPCode | 731045417 | |
| NPPES Provider State | OK | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 73.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1790754729 |
| Last Name Of The Provider | COMP |
| First Name Of The Provider | PHILIP |
| View All |
Similar Doctors
|
Dr. Thomas A. Showalter III, DO
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Khader K. Hussein, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Todd Clapp, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph A. Metz, MD |
|
|
Dr. John D. Wilkinson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Razmig G. Kratlian, MD |
|
|
Dr. Muhammad Sanaullah, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leonard M. Bowen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew Austin, DO |
|
Dr. Sherry L. Roles, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bradley C. Gehrs, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Namali Pierson, MD |